I am a
Home I AM A Search Login

Papers of the Week

2019 Aug

J Manag Care Spec Pharm



Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.


Boytsov NN, Bhattacharya R, Saverno K, Dixon L, Abbott PL, Zhang X, Gaich CL, Nair R
J Manag Care Spec Pharm. 2019 Aug; 25(8):879-887.
PMID: 31347977.


Disease-modifying antirheumatic drugs (DMARDs) are recommended as the standard of care for patients with rheumatoid arthritis (RA) due to their ability to reduce pain and disability; however, DMARD use is low in some subgroups of the RA population.